PTEN mutations have been identified in endometrial hyperplasias, as well as in carcinomas, which suggests that the level of PTEN gene expression is important in pathologies related to the female reproductive system (Maxwell et al. 1998; Salvesen et al. 2002). The gene discussed is PTEN; the disease is carcinoma.